Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Irinotecan Metabolism Pathway
Homo sapiens
Drug Metabolism Pathway
Irinotecan is a medication commonly sold as Camptosar, used to stop the growth of cancer cells, and to stop the spread of cancer cells in the human body. Specifically cancers of the rectum and of the colon. Commonly used in combination with chemotherapy. Irinotecan works through its active metabolite, SN-38, which inhibits the action of topoisomerase I. This enzyme is responsible for creating single-strand breaks in DNA during replication. These single-strands are reversible. SN-38 and Irinotecan binding to topoisomerase I-DNA complex results in the prevention of religation the DNA strand mentioned above, which creates double-strand DNA breakage. This breakage leads to cell death. Irinotecan is taken orally, but can also be injected.
References
Irinotecan Pathway References
Mathijssen RH, Loos WJ, Verweij J, Sparreboom A: Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan. Curr Cancer Drug Targets. 2002 Jun;2(2):103-23.
Pubmed: 12188913
Rothenberg ML: Topoisomerase I inhibitors: review and update. Ann Oncol. 1997 Sep;8(9):837-55.
Pubmed: 9358934
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Settings